Dr Peter Marks is resigning as director of the FDA's Center for Biologics Evaluation and Research by April 5 due to objections to RFK Jr.

Letybo (letibotulinumtoxinA-wlbg) is now available for the temporary improvement in the appearance of moderate to severe ...

Emrosi (minocycline hydrochloride extended-release capsules) is now available for the treatment of inflammatory lesions (papules and pustules) of rosacea in adults.

The heads of five different offices, among other CDC officials, resigned following the nomination of Susan Monarez for director.

Some patients with atopic dermatitis who qualify for advanced systemic therapies do not receive them or may lack improvement with these therapies.

Fine particulate matter levels in the air are associated with skin redness, potentially indicating a risk for skin conditions.

Several characteristics, including BMI and Charlson Comorbidity Index, were associated with super response to biologics in patients with psoriasis.

A memo suggests that the government may end the CDC’s HIV Prevention Division, which tracks infections and promotes prevention.

Some monotherapies have significant differences in efficacy for vitiligo, whereas other modalities have similar efficacy between therapies.

The US government's termination of funding will affect research on HIV prevention, cancer, youth suicide, bone health, and more.

The relative mortality between Black and White infants and children has increased since 1950, while the difference between adults decreased.

Rates of fatal drug overdoses are higher than expected in most states, despite a 14.5% decrease in the year leading up to June 2024.